Shaala Lamiaa A, Youssef Diaa T A, Ibrahim Sabrin R M, Mohamed Gamal A, Badr Jihan M, Risinger April L, Mooberry Susan L
Natural Products Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia.
Department of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Kingdom of Saudi Arabia.
Mar Drugs. 2014 Sep 25;12(9):5021-34. doi: 10.3390/md12095021.
In continuation of our ongoing efforts to identify bioactive compounds from Red Sea marine organisms, a new collection of the ascidian Didemnum species was investigated. Chromatographic fractionation and HPLC purification of the CH2Cl2 fraction of an organic extract of the ascidian resulted in the identification of two new spiroketals, didemnaketals F (1) and G (2). The structure determination of the compounds was completed by extensive study of 1D (1H, 13C, and DEPT) and 2D (COSY, HSQC, and HMBC) NMR experiments in addition to high-resolution mass spectral data. Didemnaketal F (1) and G (2) differ from the previously reported compounds of this class by the lack the terminal methyl ester at C-1 and the methyl functionality at C-2. Instead, 1 and 2 possess a methyl ketone moiety instead of the terminal ester. Furthermore, didemnaketal F possesses a disubstituted double bond between C-2 and C-3, while the double bond was replaced by a secondary alcohol at C-3 in didemnaketal G. In addition, they possess the unique spiroketal/hemiketal functionality which was previously reported in didemnaketal E. Didemnaketals F (1) and G (2) displayed moderate activity against HeLa cells with of IC50s of 49.9 and 14.0 µM, respectively. In addition, didemnaketal F (1) displayed potent antimicrobial activity against E. coli and C. albicans. These findings provide further insight into the biosynthetic capabilities of this ascidian and the chemical diversity as well as the biological activity of this class of compounds.
为持续从红海海洋生物中鉴定生物活性化合物,我们对海鞘类Didemnum物种的一个新样本进行了研究。对该海鞘有机提取物的二氯甲烷部分进行色谱分离和高效液相色谱纯化后,鉴定出两种新的螺缩酮,即didemnaketals F(1)和G(2)。除高分辨率质谱数据外,通过对一维(1H、13C和DEPT)和二维(COSY、HSQC和HMBC)核磁共振实验的广泛研究,完成了化合物的结构测定。Didemnaketal F(1)和G(2)与该类先前报道的化合物不同之处在于,C-1位缺少末端甲酯,C-2位缺少甲基官能团。相反,1和2具有甲基酮部分而非末端酯。此外,didemnaketal F在C-2和C-3之间有一个二取代双键,而在didemnaketal G中,该双键被C-3位的仲醇取代。此外,它们具有独特的螺缩酮/半缩酮官能团,这在didemnaketal E中曾有报道。Didemnaketals F(1)和G(2)对HeLa细胞显示出中等活性,IC50分别为49.9和14.0μM。此外,didemnaketal F(1)对大肠杆菌和白色念珠菌显示出强效抗菌活性。这些发现为深入了解这种海鞘的生物合成能力、此类化合物的化学多样性以及生物活性提供了进一步的见解。